Mereo BioPharma Group plc - American Depositary Shares (MREO)

Uncover five promising stocks under $10, each poised for gains across diverse sectors for the second quarter of 2025.

Mereo BioPharma develops therapeutics for oncology and rare diseases, with strong buy recommendations and price targets between $4 and $5.

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO) released interim data from the Phase 2 portion of the Phase 2/3 Orbit 

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading.

It's time for another dive into the latest pre-market stock movers as we check out all of the news moving shares on Tuesday morning!